<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="28473" end="28479" sStart="28333" offset="0" sid="null" wn="1" wnkey="trace%2:31:00::" annotator="veweser" text="By focusing on a period in which levels of competition were stable and where the change in the nature of competition can be &lt;b&gt;traced&lt;/b&gt; to a specific legislative act, this study is able to test for the differential impact of price vs. quality competition, without confounding by other factors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="28473" end="28479" sStart="null" offset="0" sid="null" wn="5" wnkey="trace%2:39:00::" annotator="jeneale" text="By focusing on a period in which levels of competition were stable and where the change in the nature of competition can be &lt;b&gt;traced&lt;/b&gt; to a specific legislative act, this study is able to test for the differential impact of price vs. quality competition, without confounding by other factors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="28473" end="28479" sStart="null" offset="0" sid="null" wn="3" wnkey="trace%2:38:01::" annotator="cgozo" text="By focusing on a period in which levels of competition were stable and where the change in the nature of competition can be &lt;b&gt;traced&lt;/b&gt; to a specific legislative act, this study is able to test for the differential impact of price vs. quality competition, without confounding by other factors." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-2-10.anc" start="28473" end="28479" sStart="null" offset="140" sid="r7.trace.v.0272" wn="3" wnkey="trace%2:38:01::" annotator="cgozo" text="By focusing on a period in which levels of competition were stable and where the change in the nature of competition can be traced to a specific legislative act, this study is able to test for the differential impact of price vs. quality competition, without confounding by other factors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="28473" end="28479" sStart="null" offset="0" sid="null" wn="5" wnkey="trace%2:39:00::" annotator="brubin" text="By focusing on a period in which levels of competition were stable and where the change in the nature of competition can be &lt;b&gt;traced&lt;/b&gt; to a specific legislative act, this study is able to test for the differential impact of price vs. quality competition, without confounding by other factors." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-2-10.anc" start="15474" end="15484" sStart="null" offset="182" sid="r8.suggest.v.0725" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="Average observed and predicted rates were very similar, but the variation in rates was higher for the observed rates compared with the predicted rates, suggesting substantial variations in excess mortality and quality across the sample." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-2-10.anc" start="27489" end="27496" sStart="null" offset="32" sid="r8.suggest.v.0657" wn="1" wnkey="suggest%2:32:00::" annotator="veweser" text="Prior studies, however, suggest that patient care given by same provider does not vary by payer status [ 17 18 19 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="9154" end="9159" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="cgozo" text="The dependent variables for the analyses of quality of clinical care were excess death &lt;b&gt;rates&lt;/b&gt; from all causes and from 4 specific medical conditions that have relatively high death &lt;b&gt;rates&lt;/b&gt;: acute myocardial infarction, congestive heart failure, pneumonia and stroke." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="9154" end="9159" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="cgozo" text="The dependent variables for the analyses of quality of clinical care were excess death &lt;b&gt;rates&lt;/b&gt; from all causes and from 4 specific medical conditions that have relatively high death &lt;b&gt;rates&lt;/b&gt;: acute myocardial infarction, congestive heart failure, pneumonia and stroke." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="12907" end="12911" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="cgozo" text="The mortality models were weighted by the inverse of the standard error for the predicted mortality &lt;b&gt;rate&lt;/b&gt;, to account for differences across hospitals in the accuracy of the excess mortality measures, which are due to differences in sample sizes [ 14 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="9154" end="9159" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="brubin" text="The dependent variables for the analyses of quality of clinical care were excess death &lt;b&gt;rates&lt;/b&gt; from all causes and from 4 specific medical conditions that have relatively high death &lt;b&gt;rates&lt;/b&gt;: acute myocardial infarction, congestive heart failure, pneumonia and stroke." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="9154" end="9159" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="brubin" text="The dependent variables for the analyses of quality of clinical care were excess death &lt;b&gt;rates&lt;/b&gt; from all causes and from 4 specific medical conditions that have relatively high death &lt;b&gt;rates&lt;/b&gt;: acute myocardial infarction, congestive heart failure, pneumonia and stroke." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6963-2-10.anc" start="12907" end="12911" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="brubin" text="The mortality models were weighted by the inverse of the standard error for the predicted mortality &lt;b&gt;rate&lt;/b&gt;, to account for differences across hospitals in the accuracy of the excess mortality measures, which are due to differences in sample sizes [ 14 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-2-10.anc" start="25608" end="25614" sStart="null" offset="132" sid="r9.level.n.0171" wn="1" wnkey="level%1:07:00::" annotator="cgozo" text="The impact on health outcomes in non-profit hospitals may not be as large as it might have been because expenditure levels were curtailed not only in clinical areas, but in hotel services as well, although to a much lesser degree." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6963-2-10.anc" start="12063" end="12069" sStart="null" offset="7" sid="r8.family.n.0897" wn="1" wnkey="family%1:14:02::" annotator="veweser" text="Median family income measured for the hospital's zip code area was included to capture demand effects and as a proxy for cross sectional wage variations." />
  </sentences>
</list>